We next wanted to functionally validate that our gene expression signature is enriched in genes with disease-modifying potential by testing the effects of manipulating the conserved Drosophila SK and human SK channel subunits in C9ORF72-ALS patient-derived neurons and Drosophila. The gene discussed is KCNN1; the disease is amyotrophic lateral sclerosis.